About the Authors
- Raina MacIntyre
-
* E-mail: r.macintyre@unsw.edu.au
Affiliations School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia, National Centre for Immunisation Research (NCIRS), Sydney, Australia
- Alicia Stein
-
Affiliation bioCSL, Melbourne, Australia
- Christopher Harrison
-
Affiliation Family Medicine Research Centre, University of Sydney, Sydney, Australia
- Helena Britt
-
Affiliation Family Medicine Research Centre, University of Sydney, Sydney, Australia
- Abela Mahimbo
-
Affiliation School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
- Anthony Cunningham
-
Affiliation Westmead Millennium Institute, University of Sydney, Sydney, Australia
Competing Interests
Raina MacIntyre has received funding for investigator-driven research from Merck, GSK and bioCSL. Alicia Stein is an employee of bioCSL, which distributes the zoster vaccine (ZOSTAVAX) in Australia, and holds shares in the parent company, CSL Limited. Anthony Cunningham consults for and has received honoraria from GSK, Merck and bioCSL in relation to Herpes zoster vaccines. Dr Helena Britt is Chief Investigator of, and Christopher Harrison is a senior analyst working on the BEACH program, data from which was used in this paper. The program is funded by an Australian Government Competitive Grant, and by multiple commercial organizations who have formal ‘arms length’ Research Agreements with the University of Sydney for this project. One of these organizations is bioCSL. Abela Mahimbo: None to declare. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RM AS. Analyzed the data: AS CH. Wrote the paper: RM AS CH HB AM AC. Literature review: AM.